Evelyn S. Dilsaver - 24 May 2025 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 May 2025, 16:17:15 UTC
Prior SEC filing
27 May 2025
Next SEC filing
02 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Evelyn S. Dilsaver

Key filing fact

Evelyn S. Dilsaver filed Form 4 for QuidelOrtho Corp (QDEL) on 28 May 2025.

Key facts

  • This page summarizes Evelyn S. Dilsaver's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 28 May 2025, 16:17.

Change

  • Previous filing in this sequence was filed on 27 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001391387 Primary reporting owner

Dilsaver Evelyn S

Relationship
Director
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature
/s/ Phillip S. Askim, attorney-in-fact for Evelyn S. Dilsaver
Signature date
28 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+402
Change %
+4%
Price
$0.000000
Shares after
10,544
Date
24 May 2025
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+80
Change %
+0.76%
Price
$0.000000
Shares after
10,624
Date
24 May 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units (Converted)

Options Exercise

Transaction value
$0
Shares
-402
Change %
-100%
Price
$0.000000
Shares after
0
Date
24 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
402
Exercise price
Footnotes
F2, F3
QDEL transaction Derivative

Restricted Stock Units (Premium)

Options Exercise

Transaction value
$0
Shares
-80
Change %
-100%
Price
$0.000000
Shares after
0
Date
24 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
80
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F3

Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .